Oral Lichen Planus Successfully Treated With Upadacitinib
J Drugs Dermatol. 2024 Apr 1;23(4):e104-e106. doi: 10.36849/JDD.7859.ABSTRACTWith the rise of Janus kinase (JAK) and Signal Transducer and Activator of Transcription (STAT) inhibitor use in dermatologic conditions, there has been increasing hope in treating extensive and difficult-to-treat inflammatory cutaneous conditions. Today we report a case of oral lichen planus successfully treated with an oral JAK1 inhibitor, upadacitinib. This case had been unresponsive by several standard methods but responded with 70% improvement within 1 month when treated with upadacitinib. J Drugs Dermatol. 2024;23(4):7859. doi:10.36849/JDD.7859e  .PMID:38564384 | DOI:10.36849/JDD.7859
Source: Journal of Drugs in Dermatology - Category: Dermatology Authors: Kristin Slater Katelyn Halash Francisca Kartono Source Type: research